<DOC>
	<DOCNO>NCT00112086</DOCNO>
	<brief_summary>A feasibility study neoadjuvant chemotherapy ( NAC ) follow interval cytoreductive surgery ( ICS ) postoperative chemotherapy stage III/IV mullerian carcinoma ovarian , tubal peritoneal carcinoma .</brief_summary>
	<brief_title>OVCA-NAC-P2 : Study Chemotherapy Followed Cytoreductive Surgery Ovarian , Tubal Peritoneal Cancers : JCOG0206</brief_title>
	<detailed_description>The purpose assess safety efficacy treatment start NAC know whether accurately diagnose advanced carcinoma image study , cytologic finding tumor marker without stag laparotomy laparoscopy . Fifty-six patient advanced mullerian carcinoma recruit study . After confirmation diagnosis laparoscopic inspection biopsy , patient undergo 4 cycle chemotherapy NAC follow ICS additional 4 cycle postsurgical chemotherapy . The primary endpoint proportion clinical complete remission accomplishment protocol treatment major secondary endpoint positive predictive value diagnosis laparoscopy regard tumor origin , histology stage . Based result study , conduct phase III study compare treatment start NAC primary cytoreductive surgery follow postsurgical chemotherapy .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Stage III IV m√ºllerian carcinoma prelaparoscopic clinical finding include image study ( CT , MRI ultrasonography ) Cytology ascites , pleural effusion , fluid obtain tumor centesis Malignancies origins , breast digestive tract , exclude endoscopy , opaque enema , ultrasonography malignancy suspect symptom , physical examination image diagnosis . CA125 &gt; 200U/ml CEA &lt; 20ng/ml . Clinically deem candidate debulking surgery without evidence brain , bone , bone marrow metastasis , multiple lung , multiple liver metastasis Presence least one measurable lesion Previously untreated malignancy history treatment chemotherapy radiotherapy even diseases Eastern Cooperative Oncology Group ( ECOG ) performance status 0 3 , Adequate bone marrow , hepatic , renal , cardiac respiratory function , Written inform consent . Synchronous metachronous ( within 5 year ) malignancy carcinoma situ Pregnant nursing Severe mental disorder Systemic continuous use steroidal drug Active infection Uncontrolled hypertension Diabetes mellitus , uncontrolled controlled insulin History cardiac failure , unstable angina , myocardial infarction within 6 month prior registration Liver cirrhosis bleeding tendency contraindicate debulking surgery Intestinal occlusion necessary surgical treatment Hypersensitivity alcohol</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>ovarian neoplasm</keyword>
	<keyword>laparoscopy</keyword>
	<keyword>neoadjuvant therapy</keyword>
	<keyword>interval cytoreductive surgery</keyword>
</DOC>